Zhengwen Cai
No.166 Daxuedonglu Road
Nanning, 530007, China
Nanning, 530007, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
LRPPRC promotes the progression of colorectal cancer via HIF-1ꭤ/VEGF-meditated angiogenesis.
Journal: Pathology, research and practice
Published: April 10, 2025
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: February 24, 2025
Corrigendum: Machine learning in non-small cell lung cancer radiotherapy: a bibliometric analysis.
Journal: Frontiers in oncology
Published: March 30, 2023
Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo.
Journal: Phytotherapy research : PTR
Published: January 11, 2023
Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis.
Journal: Frontiers in oncology
Published: October 28, 2022
Erratum: Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.
Journal: American journal of translational research
Published: December 21, 2019
Erratum: Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.
Journal: American journal of translational research
Published: June 14, 2018
Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.
Journal: American journal of translational research
Published: January 20, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026